Clinical trials
Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 8 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Children's Oncology Group | 2 |
| Accenture | 1 |
| Amgen | 1 |
| Amgen Research (Munich) GmbH | 1 |
| Ciusss de L'Est de l'Île de Montréal | 1 |
| Gilead Sciences | 1 |
| Hoffmann-La Roche | 1 |
| Kura Oncology, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 22 |
| Leukemia, Myeloid, Acute | 9 |
| Leukemia | 5 |
| Recurrence | 5 |
| Leukemia, Biphenotypic, Acute | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Myelodysplastic Syndromes | 4 |
| Hematologic Neoplasms | 3 |
| Multiple Myeloma | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.